Trial intelligence / Profile preview

Tourniquet vs Intraarticular Lidocaine in TKA

NCT03795805Completed

Sponsor
Instituto Mexicano del Seguro Social
Start
Mar 2018
Primary completion
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine in knee osteoarthritis (OA) (2 arms), sponsored by Instituto Mexicano del Seguro Social. Primary endpoints: Serum Creatinine at 48 hours and Acute Kidney Injury Incidence at 48 hours. Started Mar 2018; status: completed.

02

Drugs

lidocaine
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03795805.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03795805.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call